Revenue
attach_money0M USD
-
LXEOLexeo Therapeutics, Inc. Common Stock$ --
Lexeo Therapeutics, Inc. Common Stock
LXEO
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2024 Full YearUpdated: 12/31/2024
Operating Income
bar_chart-106M USD
YoY -54.4%
Net Income
verified-98M USD
YoY -48.1%
EPS
pie_chart-3.09USD
YoY -24.1%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress130.2%On Track
Revenue Progress0
Revenue Forecast1.1M
Net Income Progress-79M
Net Income Forecast-60.7M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.